Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Personalized Theratyping Trial

Trial Profile

Personalized Theratyping Trial

Not yet recruiting
Phase of Trial: Phase 0

Latest Information Update: 28 Jan 2019

At a glance

  • Drugs Ivacaftor/lumacaftor (Primary) ; Ivacaftor/tezacaftor (Primary)
  • Indications Cystic fibrosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Jan 2019 Planned primary completion date changed from 1 Jan 2020 to 1 Aug 2020.
    • 18 Jan 2019 Planned initiation date changed from 1 Jan 2019 to 1 Aug 2019.
    • 26 Oct 2018 Planned End Date changed from 1 Aug 2021 to 1 Jan 2021.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top